Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0049 | 1 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.008 | 1 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0032 | 1 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0029 | 1 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |